Apolipoproteins, friends or foes?

Frank M. Sacks, MD
Professor of Cardiovascular Disease prevention, Department of Nutrition, Harvard School of Public Health; and Professor of Medicine, Harvard Medical School and Brigham & Women's Hospital, Boston, MA, USA

Like cholesterol which circulates in blood located in VLDL, LDL, and HDL, apolipoproteins are found on each lipoprotein. Which is more important to atherosclerosis and coronary heart disease, cholesterol or apolipo - proteins? And, which apolipoproteins are harmful or helpful? The second question is much easier to answer than the first, although the literature is approaching a consensus that apolipoproteins are somewhat better predictors than cholesterol of coronary risk.

Full text » 

» 08/21 - Metabolic Syndrome traits associated with a self-reported history of kidney stones

» 08/20 - Metabolic syndrome features other than hyperglycaemia shown to increase neuropathic risk

» 08/19 - Metabolic syndrome associated with proteinuria but not independently with chronic kidney disease progression in hypertensive African-Americans

» 08/18 - Association between central adiposity and cognitive function attenuated by adjustment for physical activity

» 08/15 - High prevalence of metabolic syndrome in chronic hepatitis C virus infection associated with a lack of sustained virologic response

» 08/14 - Overweight and obesity associated with lower all-cause and cardiovascular mortality in patients with chronic heart failure

» 08/13 - Impaired glycaemic profile during pregnancy as a risk factor for important metabolic abnormalities and adverse perinatal outcomes

» 08/12 - A novel microfluidics-based method to establish HDL 2b clinical utility showing satisfactory assay performance

» 08/11 - Metabolic syndrome as predictor of coronary heart disease, ischaemic stroke, carotid artery disease and diabetes in the ARIC study

» 08/08 - Physical activity above the government-recommended level associated with progressive improvement in metabolic health with no change in body mass index or fatness

Nonfasting triglyceride levels independently associated with incident cardiovascular events

Fasting triglyceride levels show little independent association.

The importance of triglycerides in cardiovascular risk is controversial. Triglycerides are typically determined in the fasting state, yet postprandial hypertriglyceridaemia may play an important role in atherosclerosis. This study sought to determine the association of fasting versus nonfasting triglyceride levels and risk of future cardiovascular events.